Atorus™ (@AtorusR) header
Atorus™ (@AtorusR) profile picture

Your Complete Data Solution

New Jersey
Joined March 2020
Photo by Atorus™ (@AtorusR)Photo by Atorus™ (@AtorusR)Photo by Atorus™ (@AtorusR)Photo by Atorus™ (@AtorusR)Photo by Atorus™ (@AtorusR)Photo by Atorus™ (@AtorusR)Photo by Atorus™ (@AtorusR)Photo by Atorus™ (@AtorusR)Photo by Atorus™ (@AtorusR)Photo by Atorus™ (@AtorusR)
Open source isn’t static. Neither is OpenVal®. Every release lands in Hub, and Python joins R in Q1 2027. #DataThatDoes #OpenVal #OpenSource #Rstats #Python
16
Hello from Glasgow! PHUSE EU Connect is underway. Catch Aga Rasinska (11:00 GMT) and Frank Menius (12:00 GMT) on stage today, and find the Atorus team at booth #33. #PHUSE #PHUSEEU #Rstats
39
No single company solves every challenge alone. That’s why we’re a Signature PHUSE Supporter. Atorus Director of Strategy and CEO on why the community model works: youtube.com/watch?v=kET9jzlA… #DataThatDoes #Atorus #PHUSE #OpenSource #RStats
28
Most teams run exploratory and submission work in separate environments. Every move between them means a rebuild, repeat QC, and lost history. What if both lived in one validated environment? Read the blog: atorusresearch.com/one-study…
16
Three Atorus talks at #PHUSE EU Connect, Glasgow: clinical data as a product (DH01), a skeptic's guide to AI for programming (ML03), and one platform for exploratory and GxP work (ET05). Nov 15–18. Come find us at Booth #33. #DataThatDoes #Atorus #PHUSE #PHUSEEU #OpenSource #RStats
36
R is accepted in regulatory submissions. The real question is readiness: the evidence, the early decisions, and the people behind the work. Read the OpenVal® Future Forum recap: atorusresearch.com/r-is-acce… #rstats #OpenSource #ClinicalProgramming
29
Two weeks to PHUSE EU Connect. Visit the Atorus team at booth #33, and catch talks from Aga Rasinska, Frank Menius and Mike Stackhouse. atorusresearch.com/about/eve… #DataThatDoes #Atorus #PHUSE #PHUSEEU #ClinicalAnalytics #StatisticalProgramming #OpenSource #GxP #Rstats
25
The virtual OpenVal® Future Forum is tomorrow. Last chance to grab your free spot for the community session. See you there. [link] atorusresearch.com/about/eve… #OpenValFutureForum #DataThatDoes #Atorus #OpenVal #OpenSource #GxP #Rstats
24
Atorus isn’t slowing down this November: our OpenVal® Future Forum, PHUSE SDE Cary, the Bay Area Biotech-Pharma Statistics Workshop, and PHUSE EU Connect in Glasgow (booth #33). Book time with us: atorusresearch.com/events/ #DataThatDoes #OpenVal #PHUSE #ClinicalAnalytics #StatisticalProgramming #OpenSource #Rstats
25
Most teams don't come to us with one simple problem. They come with a gap: environments that feel like two different worlds, data with no clear view of database lock, a portfolio with no data strategy. Which one is yours? #Atorus #OpenVal #Ageirein #ClinicalAnalytics #AnalyticsEngineering #Biometrics #Rstats
14
One week to go: the OpenVal® Future Forum’s R in Submissions panel brings Eric Nantz, Andy Miskell, and Mike Stackhouse together on challenges in FDA reviews, where sponsors still meet pushbacks, and how to move R forward. Nov 4, free. Save your spot: atorusresearch.com/about/eve… #OpenValFutureForum #DataThatDoes #Atorus #OpenVal #GxP #ClinicalDevelopment #Rstats #OpenSource
21
Three challenges every team running R in a regulated setting face: documented evidence, reproducibility, and ongoing maintenance. OpenVal® solves all three. atorusresearch.com/openval/ #DataThatDoes #Atorus #OpenVal #OpenSource #GxPValidation #StatisticalProgramming #ClinicalAnalytics #pharmaverse #Rstats
21
Great conversations at the Veeva R&D and Quality Summit about what happens to clinical data after quality review. Ageirein™ connects with Veeva EDC and DQS so teams can move from review to data analysis in a validated environment. Our crew is in Boston, so let’s connect! #Atorus #Veeva #Ageirein #ClinicalDataManagement #VeevaSummit
31
R in submissions: What challenges come up in FDA reviews? Where’s the pushback? How is CAMIS building evidence? Hear from Eric Nantz, Andy Miskell and Mike Stackhouse at the OpenVal® Future Forum. Free to join: atorusresearch.com/about/eve… #OpenValFutureForum #DataThatDoes #Atorus #OpenVal #GxP #OpenSource #Rstats
19
The Atorus crew is headed to the Veeva R&D and Quality Summit in Boston, Oct. 20–21 Let’s talk about how Ageirein™ complements Veeva DQS atorusresearch.com/about/eve… #VeevaSummit #DataThatDoes #Atorus #Ageirein #Veeva #Rstats #ClinicalDataManagement
45
PHUSE EU Connect in Glasgow is one month out. Don't miss the sessions from Aga Rasinska, Mike Stackhouse, and Frank Menius. atorusresearch.com/about/eve… #DataThatDoes #Atorus #PHUSE #PHUSEEU #StatisticalProgramming #ClinicalAnalytics #OpenSource #GxP #Rstats
29
The data is in. Now the work shouldn't stall. Ageirein™ links dashboards and reports straight to each study, and Ageirein Flow runs R and SAS® in one automated pipeline, start to finish. atorusresearch.com/inside-th… #DataThatDoes #Atorus #Ageirein #rstats
29
OpenVal® Future Forum, Nov 4: From Adoption to Submission. Insider Session, 9 a.m. ET / 15:00 CET: customers only. Community Session, 11 a.m. ET / 17:00 CET: free and open to all, with real-world stories, a live Q&A, and an unscripted fireside panel. Register: atorusresearch.com/about/eve… #OpenValFutureForum #DataThatDoes #Atorus #OpenVal #OpenSource #ClinicalProgramming #Rstats
24
CRF annotation is where trial design intent becomes structured and machine-readable, and AI tools are only as reliable as the inputs they reason over. See the Atorus poster on eCRF Auto-Annotation at PHUSE SDE Copenhagen, Oct 22. atorusresearch.com/about/eve… #DataThatDoes #Atorus #PHUSE #CDASH #ClinicalDataManagement #ClinicalAnalytics #AI #Rstats
43
From Basel to Denver to San Diego, the Atorus team was right where the conversations were happening. One theme: the industry is rethinking how trial data gets collected, standardized, and flows into analytics. On your agenda too? Let’s talk. atorusresearch.com/contact/ #Atorus #BiotechX #CDISC #CDISCInterchange #MedidataNEXT #ClinicalData
21